Journal
JOURNAL OF BONE AND MINERAL RESEARCH
Volume 19, Issue 5, Pages 764-772Publisher
WILEY
DOI: 10.1359/JBMR.040211
Keywords
raloxifene; postmenopausal osteoporosis; risk factors; vertebral fracture
Categories
Ask authors/readers for more resources
Different risk factors may influence the effectiveness of osteoporosis therapies. The interaction of 30 baseline risk factors and the effectiveness of raloxifene in the MORE study were assessed. The efficacy of raloxifene in reducing vertebral fractures is largely independent of the presence of clinical risk factors for osteoporotic fractures.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available